Patients With DM and OH Demonstrated Higher Central BP and PWV Tags ASCVD Diabetic Neuropathy Myocardial infarction Read more about Patients With DM and OH Demonstrated Higher Central BP and PWV
Combined BP and Diabetes Therapy Improved CV Outcomes in Meta-analysis Tags ASCVD Coronary artery disease GLP-1 agonists Myocardial infarction Read more about Combined BP and Diabetes Therapy Improved CV Outcomes in Meta-analysis
SGLT2 Inhibitors Reduce CV Death or HF Hospitalization in T2DM Tags Myocardial infarction SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Reduce CV Death or HF Hospitalization in T2DM
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
Diabetes and Heart Attack Risk: What Every Patient Should Know Tags Smoking duration Coronary artery disease Myocardial infarction Read more about Diabetes and Heart Attack Risk: What Every Patient Should Know
Empagliflozin or Dapagliflozin for Cardiorenal Outcomes in T2DM? Tags Myocardial infarction Stroke SGLT-2 Inhibitor Read more about Empagliflozin or Dapagliflozin for Cardiorenal Outcomes in T2DM?
Low-Dose Colchicine Reduces MACE Risk in Diabetes Tags Myocardial infarction Stroke Read more about Low-Dose Colchicine Reduces MACE Risk in Diabetes
Waist-to-Height Ratio Reveals Cardiovascular Risk in T2DM Tags Myocardial infarction Stroke Read more about Waist-to-Height Ratio Reveals Cardiovascular Risk in T2DM
GLP-1-Based Therapies Show Distinct CV and Renal Effects in T2DM Tags Coronary artery disease Myocardial infarction GLP-1 agonists DPP-4 inhibitors Read more about GLP-1-Based Therapies Show Distinct CV and Renal Effects in T2DM
Lower eGDR Levels Indicate Higher Vascular Event Risk in T2DM Tags Coronary artery disease Myocardial infarction hBA1c Read more about Lower eGDR Levels Indicate Higher Vascular Event Risk in T2DM